Mp37-13 Accelerated Cell Proliferation and Enhanced Resistance to Docetaxel by Inhibition of 4e-Binding Protein 1 Expression in Human Castration-Resistant Prostate Cancer Pc3 Cells

Journal of Urology - Netherlands
doi 10.1016/j.juro.2015.02.1276
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

ERG Rearrangement and Protein Expression in the Progression to Castration-Resistant Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2014English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

MMP-7, sFas and FasL Serum Levels for Predicting Docetaxel Resistance and Survival in Castration-Resistant Prostate Cancer

BJU International
Urology
2018English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology
Oncology
2016English

Targeted BikDD Expression Kills Androgen-Dependent and Castration-Resistant Prostate Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

PKM2 Under Hypoxic Environment Causes Resistance to mTOR Inhibitor in Human Castration Resistant Prostate Cancer

Oncotarget
Oncology
2018English

Inhibitor SBFI26 Suppresses the Malignant Progression of Castration-Resistant PC3-M Cells by Competitively Binding to Oncogenic FABP5

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy